- Home
- DNN vs SUPN Comparison
DNN vs SUPN Comparison
Compare DNN & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNN
- SUPN
- Stock Information
- Founded
- DNN 1936
- SUPN 2005
- Country
- DNN Canada
- SUPN United States
- Employees
- DNN N/A
- SUPN N/A
- Industry
- DNN Other Metals and Minerals
- SUPN Biotechnology: Pharmaceutical Preparations
- Sector
- DNN Basic Materials
- SUPN Health Care
- Exchange
- DNN Nasdaq
- SUPN Nasdaq
- Market Cap
- DNN 1.7B
- SUPN 2.0B
- IPO Year
- DNN 1997
- SUPN 2012
- Fundamental
- Price
- DNN $2.36
- SUPN $36.57
- Analyst Decision
- DNN Strong Buy
- SUPN Hold
- Analyst Count
- DNN 2
- SUPN 1
- Target Price
- DNN $3.00
- SUPN $36.00
- AVG Volume (30 Days)
- DNN 23.3M
- SUPN 422.0K
- Earning Date
- DNN 11-07-2024
- SUPN 11-04-2024
- Dividend Yield
- DNN N/A
- SUPN N/A
- EPS Growth
- DNN N/A
- SUPN 130.79
- EPS
- DNN N/A
- SUPN 1.07
- Revenue
- DNN $2,920,167.00
- SUPN $651,972,000.00
- Revenue This Year
- DNN $272.08
- SUPN $7.82
- Revenue Next Year
- DNN $77.80
- SUPN N/A
- P/E Ratio
- DNN N/A
- SUPN $34.19
- Revenue Growth
- DNN N/A
- SUPN 6.79
- 52 Week Low
- DNN $1.40
- SUPN $25.53
- 52 Week High
- DNN $2.47
- SUPN $39.37
- Technical
- Relative Strength Index (RSI)
- DNN 61.28
- SUPN 57.63
- Support Level
- DNN $2.26
- SUPN $35.85
- Resistance Level
- DNN $2.43
- SUPN $37.23
- Average True Range (ATR)
- DNN 0.13
- SUPN 1.15
- MACD
- DNN 0.01
- SUPN -0.07
- Stochastic Oscillator
- DNN 78.00
- SUPN 49.42
About DNN Denison Mines Corp (Canada)
Denison Mines Corp is a uranium exploration and development company with interests focused in the Athabasca Basin region of northern Saskatchewan, Canada. The company has an effective 95% interest in its flagship Wheeler River Uranium Project, which is the largest undeveloped uranium project in the infrastructure-rich eastern portion of the Athabasca Basin region of northern Saskatchewan. The company is also engaged in mine decommissioning and environmental services through its Closed Mines group, which manages its Elliot Lake reclamation projects and provides third-party post-closure mine care and maintenance services.
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. The Company's diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.